353 related articles for article (PubMed ID: 29114070)
41. LOC285629 regulates cell proliferation and motility in colorectal cancer cells.
Nasir SN; Abu N; Ab Mutalib NS; Ishak M; Sagap I; Mazlan L; Rose IM; Jamal R
Clin Transl Oncol; 2018 Jun; 20(6):775-784. PubMed ID: 29098557
[TBL] [Abstract][Full Text] [Related]
42. SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival.
Schmid F; Wang Q; Huska MR; Andrade-Navarro MA; Lemm M; Fichtner I; Dahlmann M; Kobelt D; Walther W; Smith J; Schlag PM; Stein U
Oncogene; 2016 Nov; 35(46):5942-5952. PubMed ID: 26686083
[TBL] [Abstract][Full Text] [Related]
43. The RNA-binding protein ESRP1 promotes human colorectal cancer progression.
Fagoonee S; Picco G; Orso F; Arrigoni A; Longo DL; Forni M; Scarfò I; Cassenti A; Piva R; Cassoni P; Silengo L; Tolosano E; Aime S; Taverna D; Pandolfi PP; Brancaccio M; Medico E; Altruda F
Oncotarget; 2017 Feb; 8(6):10007-10024. PubMed ID: 28052020
[TBL] [Abstract][Full Text] [Related]
44. Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify.
Komor MA; Pham TV; Hiemstra AC; Piersma SR; Bolijn AS; Schelfhorst T; Delis-van Diemen PM; Tijssen M; Sebra RP; Ashby M; Meijer GA; Jimenez CR; Fijneman RJA
Mol Cell Proteomics; 2017 Oct; 16(10):1850-1863. PubMed ID: 28747380
[TBL] [Abstract][Full Text] [Related]
45. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
[TBL] [Abstract][Full Text] [Related]
46. MiR-489 suppresses tumor growth and invasion by targeting HDAC7 in colorectal cancer.
Gao S; Liu H; Hou S; Wu L; Yang Z; Shen J; Zhou L; Zheng SS; Jiang B
Clin Transl Oncol; 2018 Jun; 20(6):703-712. PubMed ID: 29071516
[TBL] [Abstract][Full Text] [Related]
47. Downregulation of
Jiao HL; Ye YP; Yang RW; Sun HY; Wang SY; Wang YX; Xiao ZY; He LQ; Cai JJ; Wei WT; Chen YR; Gu CC; Cai YL; Hu YT; Lai QH; Qiu JF; Liang L; Cao GW; Liao WT; Ding YQ
Clin Cancer Res; 2017 Nov; 23(22):7108-7118. PubMed ID: 28912140
[No Abstract] [Full Text] [Related]
48. Potential role of TRIM3 as a novel tumour suppressor in colorectal cancer (CRC) development.
Piao MY; Cao HL; He NN; Xu MQ; Dong WX; Wang WQ; Wang BM; Zhou B
Scand J Gastroenterol; 2016; 51(5):572-82. PubMed ID: 26691157
[TBL] [Abstract][Full Text] [Related]
49. High expression of PTBP1 promote invasion of colorectal cancer by alternative splicing of cortactin.
Wang ZN; Liu D; Yin B; Ju WY; Qiu HZ; Xiao Y; Chen YJ; Peng XZ; Lu CM
Oncotarget; 2017 May; 8(22):36185-36202. PubMed ID: 28404950
[TBL] [Abstract][Full Text] [Related]
50. SRSF6 balances mitochondrial-driven innate immune outcomes through alternative splicing of BAX.
Wagner AR; Weindel CG; West KO; Scott HM; Watson RO; Patrick KL
Elife; 2022 Nov; 11():. PubMed ID: 36409059
[TBL] [Abstract][Full Text] [Related]
51. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
[TBL] [Abstract][Full Text] [Related]
52. CDK5 functions as a tumor promoter in human colorectal cancer via modulating the ERK5-AP-1 axis.
Zhuang K; Zhang J; Xiong M; Wang X; Luo X; Han L; Meng Y; Zhang Y; Liao W; Liu S
Cell Death Dis; 2016 Oct; 7(10):e2415. PubMed ID: 27735944
[TBL] [Abstract][Full Text] [Related]
53. MAP2 Splicing is Altered in Huntington's Disease.
Cabrera JR; Lucas JJ
Brain Pathol; 2017 Mar; 27(2):181-189. PubMed ID: 27098187
[TBL] [Abstract][Full Text] [Related]
54. The Jun/miR-22/HuR regulatory axis contributes to tumourigenesis in colorectal cancer.
Liu Y; Chen X; Cheng R; Yang F; Yu M; Wang C; Cui S; Hong Y; Liang H; Liu M; Zhao C; Ding M; Sun W; Liu Z; Sun F; Zhang C; Zhou Z; Jiang X; Chen X
Mol Cancer; 2018 Jan; 17(1):11. PubMed ID: 29351796
[TBL] [Abstract][Full Text] [Related]
55. IQGAP1 and RNA Splicing in the Context of Head and Neck via Phosphoproteomics.
Muehlbauer LK; Wei T; Shishkova E; Coon JJ; Lambert PF
J Proteome Res; 2022 Sep; 21(9):2211-2223. PubMed ID: 35980772
[TBL] [Abstract][Full Text] [Related]
56. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer.
Tang JT; Wang JL; Du W; Hong J; Zhao SL; Wang YC; Xiong H; Chen HM; Fang JY
Carcinogenesis; 2011 Aug; 32(8):1207-15. PubMed ID: 21665895
[TBL] [Abstract][Full Text] [Related]
57. SRSF1-Regulated Alternative Splicing in Breast Cancer.
Anczuków O; Akerman M; Cléry A; Wu J; Shen C; Shirole NH; Raimer A; Sun S; Jensen MA; Hua Y; Allain FH; Krainer AR
Mol Cell; 2015 Oct; 60(1):105-17. PubMed ID: 26431027
[TBL] [Abstract][Full Text] [Related]
58. RBM4-SRSF3-MAP4K4 splicing cascade modulates the metastatic signature of colorectal cancer cell.
Lin JC; Lee YC; Tan TH; Liang YC; Chuang HC; Fann YC; Johnson KR; Lin YJ
Biochim Biophys Acta Mol Cell Res; 2018 Feb; 1865(2):259-272. PubMed ID: 29138007
[TBL] [Abstract][Full Text] [Related]
59. BCLAF1 and its splicing regulator SRSF10 regulate the tumorigenic potential of colon cancer cells.
Zhou X; Li X; Cheng Y; Wu W; Xie Z; Xi Q; Han J; Wu G; Fang J; Feng Y
Nat Commun; 2014 Aug; 5():4581. PubMed ID: 25091051
[TBL] [Abstract][Full Text] [Related]
60. U2-related proteins CHERP and SR140 contribute to colorectal tumorigenesis via alternative splicing regulation.
Wang Q; Wang Y; Liu Y; Zhang C; Luo Y; Guo R; Zhan Z; Wei N; Xie Z; Shen L; Wu G; Wu W; Feng Y
Int J Cancer; 2019 Nov; 145(10):2728-2739. PubMed ID: 30977118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]